110 related articles for article (PubMed ID: 2283585)
1. Biochemical mode of action and enantiomeric selectivity of SDZ 89-485, a new triazole antimycotic.
Ryder NS
J Med Vet Mycol; 1990; 28(5):385-94. PubMed ID: 2283585
[TBL] [Abstract][Full Text] [Related]
2. The novel azole R126638 is a selective inhibitor of ergosterol synthesis in Candida albicans, Trichophyton spp., and Microsporum canis.
Vanden Bossche H; Ausma J; Bohets H; Vermuyten K; Willemsens G; Marichal P; Meerpoel L; Odds F; Borgers M
Antimicrob Agents Chemother; 2004 Sep; 48(9):3272-8. PubMed ID: 15328084
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of action of efinaconazole, a novel triazole antifungal agent.
Tatsumi Y; Nagashima M; Shibanushi T; Iwata A; Kangawa Y; Inui F; Siu WJ; Pillai R; Nishiyama Y
Antimicrob Agents Chemother; 2013 May; 57(5):2405-9. PubMed ID: 23459486
[TBL] [Abstract][Full Text] [Related]
4. Biochemical changes associated with the antifungal action of the triazole ICI 153,066 on Candida albicans and Trichophyton quinckeanum.
Barrett-Bee K; Newboult L; Pinder P
FEMS Microbiol Lett; 1991 Apr; 63(2-3):127-31. PubMed ID: 2060756
[TBL] [Abstract][Full Text] [Related]
5. Saperconazole: a selective inhibitor of the cytochrome P-450-dependent ergosterol synthesis in Candida albicans, Aspergillus fumigatus and Trichophyton mentagrophytes.
Vanden Bossche H; Marichal P; Willemsens G; Bellens D; Gorrens J; Roels I; Coene MC; Le Jeune L; Janssen PA
Mycoses; 1990; 33(7-8):335-52. PubMed ID: 2090934
[TBL] [Abstract][Full Text] [Related]
6. Specific inhibition of fungal sterol biosynthesis by SF 86-327, a new allylamine antimycotic agent.
Ryder NS
Antimicrob Agents Chemother; 1985 Feb; 27(2):252-6. PubMed ID: 4039119
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of a new mycotic agent, piritetrate on ergosterol biosynthesis in pathogenic fungi.
Morita T; Iwata K; Nozawa Y
J Med Vet Mycol; 1989; 27(1):17-25. PubMed ID: 2666631
[TBL] [Abstract][Full Text] [Related]
8. Effects of antifungal agents on ergosterol biosynthesis in Candida albicans and Trichophyton mentagrophytes: differential inhibitory sites of naphthiomate and miconazole.
Morita T; Nozawa Y
J Invest Dermatol; 1985 Nov; 85(5):434-7. PubMed ID: 3902987
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of sterol 4-demethylation in Candida albicans by 6-amino-2-n-pentylthiobenzothiazole, a novel mechanism of action for an antifungal agent.
Kuchta T; Léka C; Farkas P; Bujdáková H; Belajová E; Russell NJ
Antimicrob Agents Chemother; 1995 Jul; 39(7):1538-41. PubMed ID: 7492100
[TBL] [Abstract][Full Text] [Related]
10. In-vitro activity of D0870, a new triazole antifungal drug, in comparison with fluconazole and itraconazole against Aspergillus fumigatus and Candida krusei.
Venkateswarlu K; Denning DW; Kelly SL
J Antimicrob Chemother; 1997 Jun; 39(6):731-6. PubMed ID: 9222042
[TBL] [Abstract][Full Text] [Related]
11. Effect of allylamine antimycotic agents on fungal sterol biosynthesis measured by sterol side-chain methylation.
Ryder NS
J Gen Microbiol; 1985 Jul; 131(7):1595-602. PubMed ID: 3900280
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo effects of the antimycotic drug ketoconazole on sterol synthesis.
Van den Bossche H; Willemsens G; Cools W; Cornelissen F; Lauwers WF; van Cutsem JM
Antimicrob Agents Chemother; 1980 Jun; 17(6):922-8. PubMed ID: 6250469
[TBL] [Abstract][Full Text] [Related]
13. Posaconazole is a potent inhibitor of sterol 14alpha-demethylation in yeasts and molds.
Munayyer HK; Mann PA; Chau AS; Yarosh-Tomaine T; Greene JR; Hare RS; Heimark L; Palermo RE; Loebenberg D; McNicholas PM
Antimicrob Agents Chemother; 2004 Oct; 48(10):3690-6. PubMed ID: 15388421
[TBL] [Abstract][Full Text] [Related]
14. A novel method for studying ergosterol biosynthesis by a cell-free preparation of Aspergillus fumigatus and its inhibition by azole antifungal agents.
Ballard SA; Ellis SW; Kelly SL; Troke PF
J Med Vet Mycol; 1990; 28(4):335-44. PubMed ID: 2176688
[TBL] [Abstract][Full Text] [Related]
15. Preclinical antimycotic activity of SDZ 89-485: a new orally and topically effective triazole.
Schaude M; Petranyi G; Ackerbauer H; Meingassner JG; Mieth H
J Med Vet Mycol; 1990; 28(6):445-54. PubMed ID: 2093117
[TBL] [Abstract][Full Text] [Related]
16. Stereoselective interaction of SCH 39304, a triazole, with sterol 14alpha-demethylase of Aspergillus fumigatus.
Venkateswarlu K; Kelly SL
J Antimicrob Chemother; 1997 May; 39(5):597-601. PubMed ID: 9184358
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of sterol 14 alpha-demethylation of Candida albicans with NND-502, a novel optically active imidazole antimycotic agent.
Niwano Y; Koga H; Kodama H; Kanai K; Miyazaki T; Yamaguchi H
Med Mycol; 1999 Oct; 37(5):351-5. PubMed ID: 10520160
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of azole antifungal activity as determined by liquid chromatographic/mass spectrometric monitoring of ergosterol biosynthesis.
Heimark L; Shipkova P; Greene J; Munayyer H; Yarosh-Tomaine T; DiDomenico B; Hare R; Pramanik BN
J Mass Spectrom; 2002 Mar; 37(3):265-9. PubMed ID: 11921367
[TBL] [Abstract][Full Text] [Related]
19. Novel high energy intermediate analogues with triazasterol-related structures as inhibitors of ergosterol biosynthesis. III. Synthesis and antifungal activity of N4-alkyl-1,6,7,11b-tetrahydro-2H-pyrimido[4,3-a]isoquinolin-4-amine salts.
Gössnitzer E; Punkenhofer A; Amon A; Favre B
Eur J Pharm Sci; 2003 Jun; 19(2-3):151-64. PubMed ID: 12791418
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol import by Aspergillus fumigatus and its influence on antifungal potency of sterol biosynthesis inhibitors.
Xiong Q; Hassan SA; Wilson WK; Han XY; May GS; Tarrand JJ; Matsuda SP
Antimicrob Agents Chemother; 2005 Feb; 49(2):518-24. PubMed ID: 15673727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
